Abstract:Background: In spinal cord injury (SCI), systemic inflammation and the death of nerve cells in the spinal cord are life threatening. The connection between gut microbiota and signaling pathways has been a hot research topic in recent years. The Toll-like receptor 4/Myeloid differentiation factor 88 (TLR4/MyD88) signaling pathway is closely related to the inflammatory response. This study explored whether the gut microbiota imbalance could affect the TLR4/MyD88 signaling pathway to regulate SCI to provide a new basis for SCI research and treatment. Methods: An SCI model was constructed to study the influence on the injury of gut microbiota. 16S amplicon sequencing was used to identify the diversity and abundance of gut microbes. Fecal microbiota transplantation was performed in mice with SCI. ELISA was used to detect the serum levels of pro-inflammatory and anti-inflammatory factors in mice. Hematoxylin and eosin staining was used to observe SCI in mice. Immunofluorescence was used to detect the rates of loss glial fibrillary acidic protein (GFAP), neuronal nuclear protein (NeuN), and ionized calcium-binding adapter molecule 1 (IBA1) in the spinal cord as indicators of apoptosis. The expression of the TLR4/MyD88 signaling pathway was detected by qRT-PCR and western blotting. Results: Significant differences were observed in the gut microbiota of SCI mice and normal mice. The gut microbiota of SCI mice was imbalanced. The levels of pro-inflammatory cytokines tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 in SCI mice were increased, as was the level of the toxic induced nitric oxide synthase. The levels of anti-inflammatory factors IL-4, transforming growth factor-β, and IL-10 were decreased, as was the level of arginase-1. The apoptosis rates of GFAP, NeuN, and IBA1 were increased. The TLR4/MyD88 signaling pathway was activated. In the SCI group, inflammation increased after fecal transplantation, apoptosis of GFAP, NeuN, and IBA1 increased, and SCI was more serious. Conclusion: The TLR4/MyD88 signaling pathway promotes the death of nerve cells by inducing inflammation. Gut microbiota dysregulation can lead to aggravated SCI by activating the TLR4/MyD88 signaling pathway.

The gut microbiota promotes distal tissue regeneration via RORy plus regulatory T cell emissaries

The gut microbiota promotes distal tissue regeneration via RORγ+ regulatory T cell emissaries.

Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners

A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation

Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury

Variation in the Gut Microbial Community is Associated with the Progression of Liver Regeneration

Erythroid differentiation regulator-1 induced by microbiota in early life drives intestinal stem cell proliferation and regeneration

Local administration of regulatory T cells promotes tissue healing

A Special Population of Regulatory T Cells Potentiates Muscle Repair

Intestinal factors promoting the development of RORγt+ cells and oral tolerance

Gut Microbiota Defines Functional Direction of Colonic Regulatory T Cells with Unique TCR Repertoires

Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration

Regulatory T cells in skeletal muscle repair and regeneration: recent insights

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease

Retinoic acid and TGF-β orchestrate organ-specific programs of tissue residency

Microbiome diversity declines while distinct expansions of Th17, iNKT, and dendritic cell subpopulations emerge after anastomosis surgery

TGFB1 induces fetal reprogramming and enhances intestinal regeneration

Gut Microbiota Disorders Promote Inflammation and Aggravate Spinal Cord Injury Through the TLR4/MyD88 Signaling Pathway

Non-TGFβ profibrotic signaling in ulcerative colitis after in vivo experimental intestinal injury in humans

Colitis-induced Upregulation of Tumor Necrosis Factor Receptor-2 (TNFR2) Terminates Epithelial Regenerative Signaling to Restore Homeostasis.

The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis